SCHEMBL15830752

SCHEMBL15830752

Cc1ccc2c(c1C)C(=O)NCCO2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 1/20 0.46
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 1/20 0.44
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
ATM Q13315 1/20 0.38
ADRA2A P08913 3/20 0.37
ADRA2C P18825 3/20 0.37
ADRA1D P25100 3/20 0.37
ADRA1A P35348 3/20 0.37
ADRA1B P35368 3/20 0.37
ADRA2B P18089 2/20 0.37
ROS1 P08922 1/20 0.36
ALK Q9UM73 1/20 0.36
HSP90AA1 P07900 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15814029 0.84 FABP6 (0.44) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL20778164 0.84 FABP6 (0.48) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL13801972 0.80 FABP6 (0.43) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL22135696 0.78 FABP6 (0.40) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL15814341 0.77 KDM4E (0.40) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL13036175 0.75 ADRA2A (0.54) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL19679352 0.72 FABP6 (0.42) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL21333603 0.71 FABP6 (0.51) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL22744294 0.71 CYP19A1 (0.47) FABP6ALDH1A1GAAHSD17B10MAPT
SCHEMBL19679348 0.71 FABP6 (0.41) FABP6ALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170233368-A1 ARYL AND HETEROARYL FUSED LACTAMS PFIZER INC. (US) 2017-08-17 US disclosed
US-20150175572-A1 ARYL AND HETEROARYL FUSED LACTAMS PFIZER INC. (US) 2015-06-25 US disclosed
US-9040515-B2 Aryl and heteroaryl fused lactams PFIZER INC. (US) 2015-05-26 US disclosed
US-20140179667-A1 ARYL AND HETEROARYL FUSED LACTAMS PFIZER INC. (US) 2014-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179667-A1 ARYL AND HETEROARYL FUSED LACTAMS CCNY, MLX, NFXL1 FABP6 4771/4885ALDH1A1 2245/4885GAA 886/4885
US-20170233368-A1 ARYL AND HETEROARYL FUSED LACTAMS CCNY, MLX, NFXL1 FABP6 4771/4885ALDH1A1 2245/4885GAA 886/4885
US-20150175572-A1 ARYL AND HETEROARYL FUSED LACTAMS CCNY, MLX, NFXL1 FABP6 4771/4885ALDH1A1 2245/4885GAA 886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.